Additional selective stresses (i.e. chemotherapy such as doxorubicin) may need to be applied to breast tumor cells to effect PKR activation with inhibition of new protein synthesis and enhanced apoptosis. The gene discussed is EIF2AK2; the disease is breast neoplasm.